home / stock / ckpt / ckpt quote
Last: | $1.90 |
---|---|
Change Percent: | 0.0% |
Open: | $1.89 |
Close: | $1.90 |
High: | $1.925 |
Low: | $1.84 |
Volume: | 155,696 |
Last Trade Date Time: | 05/31/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.9 | $1.89 | $1.9 | $1.925 | $1.84 | 155,696 | 05-31-2024 |
$1.89 | $1.81 | $1.89 | $1.92 | $1.8078 | 139,509 | 05-30-2024 |
$1.83 | $1.83 | $1.83 | $1.85 | $1.75 | 161,452 | 05-29-2024 |
$1.79 | $1.9 | $1.79 | $1.9 | $1.75 | 291,502 | 05-28-2024 |
$1.84 | $1.84 | $1.84 | $1.9 | $1.81 | 219,143 | 05-27-2024 |
$1.84 | $1.84 | $1.84 | $1.9 | $1.81 | 219,143 | 05-24-2024 |
$1.84 | $1.88 | $1.84 | $1.9138 | $1.8 | 274,331 | 05-23-2024 |
$1.85 | $2 | $1.85 | $2 | $1.85 | 407,300 | 05-22-2024 |
$1.99 | $2.09 | $1.99 | $2.11 | $1.89 | 1,139,495 | 05-21-2024 |
$2.03 | $1.89 | $2.03 | $2.12 | $1.89 | 812,769 | 05-20-2024 |
$1.88 | $1.78 | $1.88 | $1.94 | $1.7401 | 493,551 | 05-17-2024 |
$1.78 | $1.65 | $1.78 | $1.82 | $1.6 | 988,493 | 05-16-2024 |
$1.63 | $1.58 | $1.63 | $1.64 | $1.55 | 260,859 | 05-15-2024 |
$1.56 | $1.59 | $1.56 | $1.6 | $1.54 | 311,797 | 05-14-2024 |
$1.54 | $1.55 | $1.54 | $1.57 | $1.5 | 297,800 | 05-13-2024 |
$1.5 | $1.57 | $1.5 | $1.61 | $1.47 | 945,724 | 05-10-2024 |
$1.56 | $1.61 | $1.56 | $1.65 | $1.56 | 338,007 | 05-09-2024 |
$1.62 | $1.7 | $1.62 | $1.7 | $1.62 | 242,179 | 05-08-2024 |
$1.69 | $1.63 | $1.69 | $1.75 | $1.63 | 262,610 | 05-07-2024 |
$1.63 | $1.58 | $1.63 | $1.68 | $1.58 | 277,566 | 05-06-2024 |
News, Short Squeeze, Breakout and More Instantly...
Checkpoint Therapeutics Inc. Company Name:
CKPT Stock Symbol:
NASDAQ Market:
LOS ANGELES, May 28, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class a...
WALTHAM, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ:CKPT), a clinical-stage immunotherapy and ...
WALTHAM, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that James Oliviero, President and Chief Executive Officer, will participate in a fireside chat...